Skip to main content

Advertisement

SpringerLink
Log in

Sex and Management of Rheumatoid Arthritis

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease more common in women than men (3:1). Although sex-based differences may play a complex role in promoting an autoimmune dysfunction, to date the comprehensive knowledge of the link between sex and RA is still partially lacking. Furthermore, males and females have been demonstrated to differently deal with their chronic pathologies, modifying the perceived sex-based burden of disease. Gender medicine is a newly approach focusing on the impact of gender differences on human physiology, pathophysiology, and clinical features of diseases, analyzing the complex interrelation and integration of sex and psychological and cultural behavior. A better comprehension of possible factors influencing sexual dimorphism in RA susceptibility, pattern of presentation, disease activity, and outcome could contribute to a tailored approach, in order to limit the morbidity of the disease. RA disease activity seems to be higher in women, whereas the response rate to synthetic and biologic disease-modifying therapies appears to be better in males. Moreover, the common strategies for RA management may be affected by concomitant pregnancy or childbearing desire, with particular regard to treatments with potential teratogenic effects or impact on fertility. Finally, comorbidities, such as fibromyalgia, major depression, and osteoporosis, are more frequent in females, while the impact of sex on cardiovascular risk is still controversial. Moving from the role of sex in influencing RA pathogenesis, epidemiology, and disease characteristics, this review explores the evidence on how sex can have an impact on strategies for managing patients with RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M (2008) Is autoimmunity a matter of sex? Autoimmun Rev 7(8):626–630. https://doi.org/10.1016/j.autrev.2008.06.009

    Article  CAS  PubMed  Google Scholar 

  2. Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38(2-3):J282–J291. https://doi.org/10.1016/j.jaut.2011.11.013

    Article  CAS  PubMed  Google Scholar 

  3. Smolen JS, Aletaha D, Mcinnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8

    Article  CAS  PubMed  Google Scholar 

  4. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2010) Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheumatol 62(6):1576–1582. https://doi.org/10.1002/art.27425

    Article  Google Scholar 

  5. Ghosh S, Klein RS (2017) Sex drives dimorphic immune responses to viral infections. J Immunol 198(5):1782–1790. https://doi.org/10.4049/jimmunol.1601166

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Furman D (2015) Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. Expert Rev Vaccines 14(3):461–471. https://doi.org/10.1586/14760584.2015.966694

    Article  CAS  PubMed  Google Scholar 

  7. Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol 35(3):347–369. https://doi.org/10.1016/j.yfrne.2014.04.004

    Article  CAS  PubMed  Google Scholar 

  8. Kovacs WJ, Olsen NJ (2011) Sexual dimorphism of RA manifestations: genes, hormones and behavior. Nat Rev Rheumatol 7(5):307–310. https://doi.org/10.1038/nrrheum.2010.231

    Article  CAS  PubMed  Google Scholar 

  9. Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V (2013) Gender medicine: a task for the third millennium. Clin Chem Lab Med 51(4):713–727. https://doi.org/10.1515/cclm-2012-0849

    Article  CAS  PubMed  Google Scholar 

  10. Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse MEB, Costedoat-Chalumeau N, Cutolo M, Dolhain R, Fenstad MH, Förger F, Wahren-Herlenius M, Ruiz-Irastorza G, Koksvik H, Nelson-Piercy C, Shoenfeld Y, Tincani A, Villiger PM, Wallenius M, von Wolff M (2015) State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun Rev 14(5):376–386. https://doi.org/10.1016/j.autrev.2014.12.011

    Article  PubMed  Google Scholar 

  11. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977. https://doi.org/10.1136/annrheumdis-2016-210715

    Article  Google Scholar 

  12. Singh JA, Saag KG, Bridges SL et al (2016) 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68(1):1–26. https://doi.org/10.1002/art.39480

    Article  PubMed  Google Scholar 

  13. Gerosa M, De Angelis V, Riboldi P, Meroni PL (2008) Rheumatoid arthritis: a female challenge. Women’s Health 4(2):195–201. https://doi.org/10.2217/17455057.4.2.195

    Article  CAS  PubMed  Google Scholar 

  14. Symmons DPM, Barrett EM, Bankhead CR et al (1994) The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 33(8):735–739. https://doi.org/10.1093/rheumatology/33.8.735

    Article  CAS  PubMed  Google Scholar 

  15. Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y (2016) Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 52(2):205–212. https://doi.org/10.4415/ANN_16_02_12

    Article  CAS  PubMed  Google Scholar 

  16. de Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW (2008) Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 59(9):1241–1248. https://doi.org/10.1002/art.24003

    Article  PubMed  Google Scholar 

  17. Brennan P, Bankhead C, Silman AJ, Symmons DPM (1997) Oral contraceptives and rheumatoid arthritis: results from a primary care-based incident case-control study. Semin Arthritis Rheum 26(6):817–823. https://doi.org/10.1016/S0049-0172(97)80025-X

    Article  CAS  PubMed  Google Scholar 

  18. D’Elia HF, Larsen A, Mattsson L-A, Waltbrand E, Kvist G, Mellström D, Saxne T, Ohlsson C, Nordborg E, Carlsten H (2003) Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol 30(7):1456–1463

    PubMed  Google Scholar 

  19. Hall GM, Daniels M, Huskisson EC, Spector TD (1994) A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis 53(2):112–116. https://doi.org/10.1136/ard.53.2.112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. MacDonald AG, Murphy EA, Capell HA, Bankowska UZ, Ralston SH (1994) Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study. Ann Rheum Dis 53(1):54–57. https://doi.org/10.1136/ard.53.1.54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Carlsten H (2005) Immune responses and bone loss: the estrogen connection. Immunol Rev 208(1):194–206. https://doi.org/10.1111/j.0105-2896.2005.00326.x

    Article  CAS  PubMed  Google Scholar 

  22. Cutolo M (2009) Androgens in rheumatoid arthritis: when are they effectors? Arthritis Res Ther 11(5):126. https://doi.org/10.1186/ar2804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Krishnan E, Sokka T, Hannonen P (2003) Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther 5(3):R158–R162. https://doi.org/10.1186/ar750

    Article  PubMed  PubMed Central  Google Scholar 

  24. Weyand CM, Schmidt D, Wagner U, Goronzy JJ (1998) The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum 41(5):817–822. https://doi.org/10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S

    Article  CAS  PubMed  Google Scholar 

  25. Gossec L, Baro-Riba J, Bozonnat M-C, Daurès JP, Sany J, Eliaou JF, Combe B (2005) Influence of sex on disease severity in patients with rheumatoid arthritis. J Rheumatol 32(8):1448–1451

    PubMed  Google Scholar 

  26. Jawaheer D, Maranian P, Park G et al (2010) Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 37(12):2475–2485. https://doi.org/10.3899/jrheum.091432

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, da Silva JA, van Riel PL (2001) Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 28(8):1809–1816

    CAS  PubMed  Google Scholar 

  28. Tengstrand B, Ahlmén M, Hafström I (2004) The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J Rheumatol 31(2):214–222

    PubMed  Google Scholar 

  29. Iikuni N, Sato E, Hoshi M et al (2009) The influence of sex on patients with rheumatoid arthritis in a large observational cohort. J Rheumatol 36(3):508–511. https://doi.org/10.3899/jrheum.080724

    Article  PubMed  Google Scholar 

  30. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Géher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro Gda R, Karateev D, Andersone D, Rexhepi S, Yazici Y, Pincus T, QUEST-RA Group (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11(1):R7. https://doi.org/10.1186/ar2591

    Article  PubMed  PubMed Central  Google Scholar 

  31. Jawaheer D, Lum RF, Gregersen PK, Criswell LA (2006) Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum 54(10):3087–3094. https://doi.org/10.1002/art.22120

    Article  PubMed  Google Scholar 

  32. Kvien TK, Heiberg, Lie E, Kaufmann C, Mikkelsen K, Nordvåg BY, Rødevand E (2005) A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 23(5 Suppl 39):S188–S194

    CAS  PubMed  Google Scholar 

  33. Camacho EM, Verstappen SMM, Lunt M, Bunn DK, Symmons DPM (2011) Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Care Res 63(12):1745–1752. https://doi.org/10.1002/acr.20609

    Article  Google Scholar 

  34. Jawaheer D, Messing S, Reed G, Ranganath VK, Kremer JM, Louie JS, Khanna D, Greenberg JD, Furst DE (2012) Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients. Arthritis Care Res 64(12):1811–1818. https://doi.org/10.1002/acr.21762

    Article  Google Scholar 

  35. Barsky AJ, Peekna HM, Borus JF (2001) Somatic symptom reporting in women and men. J Gen Intern Med 16(4):266–275. https://doi.org/10.1046/j.1525-1497.2001.00229.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Keogh E, Herdenfeldt M (2002) Gender, coping and the perception of pain. Pain 97(3):195–201. https://doi.org/10.1016/S0304-3959(01)00427-4

    Article  PubMed  Google Scholar 

  37. Loge JH, Kaasa S (1998) Short Form 36 (SF-36) Health Survey: normative data from the general Norwegian population. Scand J Soc Med 26(4):250–258. https://doi.org/10.1177/14034948980260040401

    Article  CAS  PubMed  Google Scholar 

  38. Bowling A, Bond M, Jenkinson C, Lamping D (1999) Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey. J Public Health 21(3):255–270. https://doi.org/10.1093/pubmed/21.3.255

    Article  CAS  Google Scholar 

  39. Kvien TK, Uhlig T, Ødegård S, Heiberg MS (2006) Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci 1069(1):212–222. https://doi.org/10.1196/annals.1351.019

    Article  PubMed  Google Scholar 

  40. Ødegård S, Landewé R, van der Heijde DM et al (2005) Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum 54(1):68–75. https://doi.org/10.1002/art.21548

    Article  Google Scholar 

  41. Wolfe F, Sharp JT (1998) Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 41(9):1571–1582. https://doi.org/10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R

    Article  CAS  PubMed  Google Scholar 

  42. Yunus MB (2001) The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep 3(2):128–134. https://doi.org/10.1007/s11926-001-0008-3

    Article  CAS  PubMed  Google Scholar 

  43. Wolfe F, Michaud K (2004) Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. J Rheumatol 31(4):695–700

    PubMed  Google Scholar 

  44. Albert PR (2015) Why is depression more prevalent in women? J Psychiatry Neurosci 40(4):219–221. https://doi.org/10.1503/jpn.150205

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kuehner C (2017) Why is depression more common among women than among men? Lancet Psychiatry 4(2):146–158. https://doi.org/10.1016/S2215-0366(16)30263-2

    Article  PubMed  Google Scholar 

  46. Margaretten M, Julian L, Katz P, Yelin E (2011) Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 6(2):617–623. https://doi.org/10.2217/IJR.11.6

    Article  Google Scholar 

  47. Ranzolin A, Brenol JCT, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, Xavier RM (2009) Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and Short Form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 61(6):794–800. https://doi.org/10.1002/art.24430

    Article  PubMed  Google Scholar 

  48. Imran MY, Saira Khan EA, Ahmad NM et al (2015) Depression in rheumatoid arthritis and its relation to disease activity. Pak J Med Sci 31(2):393–397. https://doi.org/10.12669/pjms.312.6589

    Article  PubMed  PubMed Central  Google Scholar 

  49. Naranjo A, Ojeda S, Francisco F, Erausquin C, Rúa-Figueroa I, Rodríguez-Lozano C (2002) Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability. Ann Rheum Dis 61(7):660–661. https://doi.org/10.1136/ard.61.7.660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Margaretten M, Yelin E, Imboden J, Graf J, Barton J, Katz P, Julian L (2009) Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum 61(11):1586–1591. https://doi.org/10.1002/art.24822

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53(10):1759–1766. https://doi.org/10.1093/rheumatology/keu162

    Article  CAS  Google Scholar 

  52. Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, Hein G (2008) Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int 28(11):1143–1150. https://doi.org/10.1007/s00296-008-0576-x

    Article  PubMed  Google Scholar 

  53. Maricic M (2011) Update on glucocorticoid-induced osteoporosis. Rheum Dis Clin N Am 37(3):415–431– vi. https://doi.org/10.1016/j.rdc.2011.07.003

    Article  Google Scholar 

  54. Talsania M, Scofield RH (2017) Menopause and rheumatic disease. Rheum Dis Clin N Am 43(2):287–302. https://doi.org/10.1016/j.rdc.2016.12.011

    Article  Google Scholar 

  55. Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11(12):693–704. https://doi.org/10.1038/nrrheum.2015.112

    Article  CAS  PubMed  Google Scholar 

  56. Martin LA, Critelli JW, Doster JA, Powers C, Purdum M, Doster MR, Lambert PL (2013) Cardiovascular risk: gender differences in lifestyle behaviors and coping strategies. Int J Behav Med 20(1):97–105. https://doi.org/10.1007/s12529-011-9204-3

    Article  PubMed  Google Scholar 

  57. Wenger NK (2011) Gender differences in cardiovascular risk: a varying variable. Gend Med 8(4):221–223. https://doi.org/10.1016/j.genm.2011.05.004

    Article  PubMed  Google Scholar 

  58. Fransen J, Kazemi-Bajestani SMR, Bredie SJH, Popa CD (2016) Rheumatoid arthritis disadvantages younger patients for cardiovascular diseases: a meta-analysis. PLoS One 11(6):e0157360. https://doi.org/10.1371/journal.pone.0157360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Forslind K, Hafström I, Ahlmén M et al (2006) Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66(1):46–52. https://doi.org/10.1136/ard.2006.056937

    Article  PubMed  Google Scholar 

  60. Jayakumar K, Norton S, Dixey J, James D, Gough A, Williams P, Prouse P, Young A, on behalf of the Early Rheumatoid Arthritis Study (ERAS) (2012) Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology (Oxford) 51(1):169–175. https://doi.org/10.1093/rheumatology/ker250

    Article  Google Scholar 

  61. Sokka T, Hetland ML, Mäkinen H, Kautiainen H, Hørslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimić A, Nedović J, Stanković A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group (2008) Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 58(9):2642–2651. https://doi.org/10.1002/art.23794

    Article  PubMed  Google Scholar 

  62. Hyrich KL, Watson KD, Silman AJ, Symmons DPM, The BSR Biologics Register (2006) Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 45(12):1558–1565. https://doi.org/10.1093/rheumatology/kel149

    Article  CAS  Google Scholar 

  63. Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, Massara A, Nacci F, Secchi ME, Manganelli S, Salaffi F, Bambara ML, Bombardieri S, Cutolo M, Ferri C, Galeazzi M, Gerli R, Giacomelli R, Grassi W, Lapadula G, Cerinic MM, Montecucco C, Trotta F, Triolo G, Valentini G, Valesini G, Ferraccioli GF, GISEA group (2007) Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol 34(8):1670–1673

    CAS  PubMed  Google Scholar 

  64. Jawaheer D, Olsen J, Hetland ML (2012) Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis—results from the DANBIO registry. J Rheumatol 39(1):46–53. https://doi.org/10.3899/jrheum.110548

    Article  PubMed  Google Scholar 

  65. Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, Zisopoulos D, Skopouli FN, Iliopoulos A, Bertsias GK, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P (2013) Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: low rates of remission and 5-year drug survival. Semin Arthritis Rheum 43(4):447–457. https://doi.org/10.1016/j.semarthrit.2013.07.011

    Article  CAS  PubMed  Google Scholar 

  66. Marchesoni A, Zaccara E, Gorla R, Bazzani C, Sarzi-Puttini P, Atzeni F, Caporali R, Bobbio-Pallavicini F, Favalli EG (2009) TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice. Ann N Y Acad Sci 1173(1):837–846. https://doi.org/10.1111/j.1749-6632.2009.04621.x

    Article  CAS  PubMed  Google Scholar 

  67. Markenson JA, Gibofsky A, Palmer WR et al (2011) Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry. J Rheumatol 38(7):1273–1281. https://doi.org/10.3899/jrheum.101142

    Article  CAS  PubMed  Google Scholar 

  68. Iannone F, Santo L, Anelli MG, Bucci R, Semeraro A, Quarta L, D’Onofrio F, Marsico A, Carlino G, Casilli O, Cacciapaglia F, Zuccaro C, Falappone PC, Cantatore FP, Muratore M, Lapadula G (2017) Golimumab in real-life settings: 2 years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Semin Arthritis Rheum 47(1):108–114. https://doi.org/10.1016/j.semarthrit.2017.01.008

    Article  CAS  PubMed  Google Scholar 

  69. Kievit W, Fransen J, Adang EMM, den Broeder AA, Bernelot Moens HJ, Visser H, van de Laar MAF, van Riel PLCM (2011) Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register. Rheumatology (Oxford) 50(1):196–203. https://doi.org/10.1093/rheumatology/keq325

    Article  CAS  Google Scholar 

  70. Kristensen LE, Kapetanovic MC, Gulfe A, Soderlin M, Saxne T, Geborek P (2008) Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 47(4):495–499. https://doi.org/10.1093/rheumatology/ken002

    Article  CAS  Google Scholar 

  71. Souto A, Maneiro JR, Gomez-Reino JJ (2016) Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases. Rheumatology (Oxford) 55:523–534. https://doi.org/10.1093/rheumatology/kev374

    Article  CAS  Google Scholar 

  72. Leffers HC, Østergaard M, Glintborg B et al (2011) Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry. Ann Rheum Dis 70(7):1216–1222. https://doi.org/10.1136/ard.2010.140129

    Article  CAS  PubMed  Google Scholar 

  73. Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, Houvenagel E, Gaudin P, Loeuille D, Rist S, Dougados M, Sibilia J, le Loët X, Marcelli C, Bardin T, Pane I, Baron G, Mariette X (2012) Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the “Orencia and Rheumatoid Arthritis” registry. Ann Rheum Dis 71(11):1815–1819. https://doi.org/10.1136/annrheumdis-2011-201109

    Article  CAS  PubMed  Google Scholar 

  74. Gottenberg JE, Courvoisier DS, Hernández MV et al (2016) Association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the Pan-European Registry Analysis. Arthritis Rheumatol 68(6):1346–1352. https://doi.org/10.1002/art.39595

    Article  CAS  PubMed  Google Scholar 

  75. Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Pavelka K, Chartier M, Poncet C, Rauch C, le Bars M (2015) Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study. BMC Musculoskelet Disord 16(1):176. https://doi.org/10.1186/s12891-015-0636-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Soliman MM, Hyrich KL, Lunt M et al (2012) Effectiveness of rituximab in patients with rheumatoid arthritis: observational study from the British Society for Rheumatology Biologics Register. J Rheumatol 39(2):240–246. https://doi.org/10.3899/jrheum.110610

    Article  CAS  PubMed  Google Scholar 

  77. Couderc M, Gottenberg J-E, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, le Loet X, Shaeverbeke T, Ravaud P, Soubrier M, on behalf of Club Rhumatismes et Inflammations (2014) Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry. Rheumatology (Oxford) 53(10):1788–1793. https://doi.org/10.1093/rheumatology/keu176

    Article  CAS  Google Scholar 

  78. Pers Y-M, Schaub R, Constant E, Lambert J, Godfrin-Valnet M, Fortunet C, Bourichi W, Prades BP, Wendling D, Gaudin P, Jorgensen C, Maillefert JF, Marotte H (2015) Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis. Joint Bone Spine 82(1):25–30. https://doi.org/10.1016/j.jbspin.2014.07.010

    Article  CAS  PubMed  Google Scholar 

  79. Neovius M, Arkema EV, Olsson H, Eriksson JK, Kristensen LE, Simard JF, Askling J, ARTIS Study Group (2015) Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab. Ann Rheum Dis 74(2):354–360. https://doi.org/10.1136/annrheumdis-2013-204128

    Article  CAS  PubMed  Google Scholar 

  80. Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, Rubison M (1998) Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 158(9):981–988. https://doi.org/10.1001/archinte.158.9.981

    Article  CAS  PubMed  Google Scholar 

  81. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, Gieseler U, Voigtländer T, Hauptmann KE, Wagner S, Senges J (2002) Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). AJC 89(5):511–517. https://doi.org/10.1016/S0002-9149(01)02289-5

    Article  Google Scholar 

  82. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, Hazes JMW (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111(6):446–451. https://doi.org/10.1016/S0002-9343(01)00872-5

    Article  CAS  PubMed  Google Scholar 

  83. Palm O, Purinszky E (2005) Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 64(8):1227–1228. https://doi.org/10.1136/ard.2004.031716

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Mansfield A, Addis M, Mahalik J (2003) “Why won’t he go to the doctor?”: The psychology of men’s help seeking. Int J Men’s Health 2(2):93–109. https://doi.org/10.3149/jmh.0202.93

    Article  Google Scholar 

  85. Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795–810. https://doi.org/10.1136/annrheumdis-2015-208840

    Article  CAS  Google Scholar 

  86. Favalli EG, Biggioggero M, Meroni PL (2014) Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an “anchor” drug? Autoimmun Rev 13(11):1102–1108. https://doi.org/10.1016/j.autrev.2014.08.026

    Article  CAS  PubMed  Google Scholar 

  87. Förger F, Villiger PM (2016) Treatment of rheumatoid arthritis during pregnancy: present and future. Expert Rev Clin Immunol 12(9):937–944. https://doi.org/10.1080/1744666X.2016.1184973

    Article  CAS  PubMed  Google Scholar 

  88. Gerosa M, Schioppo T, Meroni PL (2016) Challenges and treatment options for rheumatoid arthritis during pregnancy. Expert Opin Pharmacother 17(11):1539–1547. https://doi.org/10.1080/14656566.2016.1197204

    Article  CAS  PubMed  Google Scholar 

  89. Benediktsson R, Calder AA, Edwards CR, Seckl JR (1997) Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 46(2):161–166. https://doi.org/10.1046/j.1365-2265.1997.1230939.x

    Article  CAS  Google Scholar 

  90. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H (1996) Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36(5):248–255. https://doi.org/10.1111/j.1600-0897.1996.tb00172.x

    Article  CAS  PubMed  Google Scholar 

  91. Porter C, Armstrong-Fisher S, Kopotsha T, Smith B, Baker T, Kevorkian L, Nesbitt A (2016) Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer. J Reprod Immunol 116:7–12. https://doi.org/10.1016/j.jri.2016.04.284

    Article  CAS  PubMed  Google Scholar 

  92. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT (2013) Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 11(3):286–292. https://doi.org/10.1016/j.cgh.2012.11.011

    Article  CAS  PubMed  Google Scholar 

  93. Mariette X, Flynn A, Förger F et al (2017) Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, multicenter, pharmacokinetic study [abstract]. Ann Rheum Dis 76:57

    Google Scholar 

  94. Østensen M (2017) The use of biologics in pregnant patients with rheumatic disease. Expert Rev Clin Pharmacol 10(6):661–669. https://doi.org/10.1080/17512433.2017.1305268

    Article  CAS  PubMed  Google Scholar 

  95. Sangle SR, Lutalo PMK, Davies RJ, Khamashta MA, D’Cruz DP (2013) B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases. J Autoimmun 43:55–59. https://doi.org/10.1016/j.jaut.2013.03.001

    Article  CAS  PubMed  Google Scholar 

  96. Hoeltzenbein M, Beck E, Rajwanshi R, Gøtestam Skorpen C, Berber E, Schaefer C, Østensen M (2016) Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data. Semin Arthritis Rheum 46(2):238–245. https://doi.org/10.1016/j.semarthrit.2016.05.004

    Article  CAS  PubMed  Google Scholar 

  97. Kumar M, Ray L, Vemuri S, Simon TA (2015) Pregnancy outcomes following exposure to abatacept during pregnancy. Semin Arthritis Rheum 45(3):351–356. https://doi.org/10.1016/j.semarthrit.2015.06.016

    Article  CAS  PubMed  Google Scholar 

  98. Chang Z, Spong CY, Jesus AA, Davis MA, Plass N, Stone DL, Chapelle D, Hoffmann P, Kastner DL, Barron K, Goldbach-Mansky RT, Stratton P (2014) Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS). Arthritis Rheumatol 66(11):3227–3232. https://doi.org/10.1002/art.38811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Nelson JL, Østensen M (1997) Pregnancy and rheumatoid arthritis. Rheum Dis Clin N Am 23(1):195–212. https://doi.org/10.1016/S0889-857X(05)70323-9

    Article  CAS  Google Scholar 

  100. Barrett JH, Brennan P, Fiddler M, Silman AJ (1999) Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 42(6):1219–1227. https://doi.org/10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G

    Article  CAS  PubMed  Google Scholar 

  101. Camacho EM, Farragher TM, Lunt M, Verstappen SMM, Bunn D, Symmons DPM (2010) The relationship between post-onset pregnancy and functional outcome in women with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Ann Rheum Dis 69(10):1834–1837. https://doi.org/10.1136/ard.2010.128769

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Nørgaard M, Larsson H, Pedersen L, Granath F, Askling J, Kieler H, Ekbom A, Sørensen HT, Stephansson O (2010) Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 268(4):329–337. https://doi.org/10.1111/j.1365-2796.2010.02239.x

    Article  PubMed  Google Scholar 

  103. Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES (2004) Association of rheumatologic disease with preeclampsia. Obstet Gynecol 103(6):1190–1193. https://doi.org/10.1097/01.AOG.0000126279.87151.e1

    Article  PubMed  Google Scholar 

  104. Skomsvoll JF, Østensen M, Irgens LM, Baste V (1999) Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway. Scand J Rehabil Med 28(6):352–356. https://doi.org/10.1080/03009749950155337

    Article  CAS  Google Scholar 

  105. Bharti B, Lee SJ, Lindsay SP, Wingard DL, Jones KL, Lemus H, Chambers CD (2015) Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project. J Rheumatol 42(8):1376–1382. https://doi.org/10.3899/jrheum.140583

    Article  PubMed  Google Scholar 

  106. Chighizola CB, Raimondo MG, Meroni PL (2017) Does APS impact women’s fertility? Curr Rheumatol Rep 19(6):33. https://doi.org/10.1007/s11926-017-0663-7

    Article  PubMed  Google Scholar 

  107. Martínez-Sánchez N, Pérez-Pinto S, Robles-Marhuenda Á, Arnalich-Fernández F, Martín Cameán M, Hueso Zalvide E, Bartha JL (2017) Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study. Immunol Res 65(2):487–494. https://doi.org/10.1007/s12026-016-8888-5

    Article  CAS  PubMed  Google Scholar 

  108. Østensen M (2017) Preconception counseling. Rheum Dis Clin N Am 43(2):189–199. https://doi.org/10.1016/j.rdc.2016.12.003

    Article  Google Scholar 

  109. Østensen M, Villiger PM (2007) The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol 29(2):185–191. https://doi.org/10.1007/s00281-007-0072-5

    Article  PubMed  Google Scholar 

  110. Tang MW, Garcia S, Gerlag DM, Tak PP, Reedquist KA (2017) Insight into the endocrine system and the immune system: a review of the inflammatory role of prolactin in rheumatoid arthritis and psoriatic arthritis. Front Immunol 8. https://doi.org/10.3389/fimmu.2017.00720

  111. Hurley WL, Theil PK (2011) Perspectives on immunoglobulins in colostrum and milk. Nutrients 3(12):442–474. https://doi.org/10.3390/nu3040442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Clowse MEB, Förger F, Hwang CC et al (2017) Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicenter, pharmacokinetic study [abstract]. Ann Rheum Dis 76:548

    Article  Google Scholar 

  113. Bragnes Y, Boshuizen R, de Vries A, Lexberg Å, Østensen M (2017) Low level of rituximab in human breast milk in a patient treated during lactation. Rheumatology (Oxford) 56(6):1047–1048. https://doi.org/10.1093/rheumatology/kex039

    Article  CAS  Google Scholar 

  114. Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K (2012) Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 64(5):668–674. https://doi.org/10.1002/acr.21593

    Article  Google Scholar 

  115. Brouwer J, Hazes JMW, Laven JSE, Dolhain RJEM (2015) Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis 74(10):1836–1841. https://doi.org/10.1136/annrheumdis-2014-205383

    Article  CAS  PubMed  Google Scholar 

  116. Ince-Askan H, Dolhain RJEM (2015) Pregnancy and rheumatoid arthritis. Best Pract Res Clin Rheumatol 29(4-5):580–596. https://doi.org/10.1016/j.berh.2015.07.001

    Article  PubMed  Google Scholar 

  117. Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KA, Nordvag BY, Koldingsnes W, Mikkelsen K, Kaufmann C, Kvien TK (2011) Fertility in women with chronic inflammatory arthritides. Rheumatology (Oxford) 50(6):1162–1167. https://doi.org/10.1093/rheumatology/keq458

    Article  Google Scholar 

  118. de Jong PHP, Dolhain RJEM (2017) Fertility, pregnancy, and lactation in rheumatoid arthritis. Rheum Dis Clin N Am 43(2):227–237. https://doi.org/10.1016/j.rdc.2016.12.004

    Article  Google Scholar 

  119. Provost M, Eaton JL, Clowse MEB (2014) Fertility and infertility in rheumatoid arthritis. Curr Opin Rheumatol 26(3):308–314. https://doi.org/10.1097/BOR.0000000000000058

    Article  PubMed  Google Scholar 

  120. Brouwer J, Laven JSE, Hazes JMW, Schipper I, Dolhain RJEM (2013) Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res 65(9):1534–1538. https://doi.org/10.1002/acr.22013

    Article  CAS  Google Scholar 

  121. Whirledge S, Cidlowski JA (2013) A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary. Endocrinology 154(12):4450–4468. https://doi.org/10.1210/en.2013-1652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. O’Morain C, Smethurst P, Doré CJ, Levi AJ (1984) Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 25(10):1078–1084. https://doi.org/10.1136/gut.25.10.1078

    Article  PubMed  PubMed Central  Google Scholar 

  123. Gutierrez JC, Hwang K (2017) The toxicity of methotrexate in male fertility and paternal teratogenicity. Expert Opin Drug Metab Toxicol 13(1):51–58. https://doi.org/10.1080/17425255.2017.1230198

    Article  CAS  PubMed  Google Scholar 

  124. Puchner R, Danninger K, Puchner A, Pieringer H (2012) Impact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conception. Clin Exp Rheumatol 30(5):765–767

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Gaetano Pini Institute, Via Gaetano Pini, 9, 20122, Milan, Italy

    Ennio Giulio Favalli & Andrea Becciolini

  2. Department of Clinical Sciences and Community Health, Division of Rheumatology, Gaetano Pini Institute, University of Milan, Milan, Italy

    Martina Biggioggero, Chiara Crotti & Maria Gabriella Raimondo

  3. Department of Clinical Sciences and Community Health, University of Milan and IRCCS Istituto Auxologico Italiano, Milan, Italy

    Pier Luigi Meroni

Authors
  1. Ennio Giulio Favalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martina Biggioggero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiara Crotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Becciolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Gabriella Raimondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pier Luigi Meroni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ennio Giulio Favalli.

Ethics declarations

Ethical Statement

The paper is a review of the literature; thus, no original clinical data are reported. Therefore, no ethical approval and informed consent are needed for the publication.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Favalli, E.G., Biggioggero, M., Crotti, C. et al. Sex and Management of Rheumatoid Arthritis. Clinic Rev Allerg Immunol 56, 333–345 (2019). https://doi.org/10.1007/s12016-018-8672-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-018-8672-5

Keywords

Search

Navigation